Clinical Trials Browser

Phase 1 × Has results × Moxifloxacin × Clear all

NCT02056392 2015-11-09

To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers

Phase 1 Completed

54 enrolled 31 charts

Other solid neoplasm

Solid Tumours